Login

Financial Snapshot

Revenue
TTM
$8.262B
Gross Margin
TTM
53.65%
Net Income
TTM
$1.432B
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
107.08%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$4.969B
Cash
2026 Q1
P/E
TTM
9.476
Free Cash Flow
TTM
-$196.0M

Stock Price

Loading...
Market Cap: $13.57 Billion

About Solventum Corp

The filing excerpts provided do not contain sufficient substantive content about Solventum Corp (NYSE: SOLV) to produce a SEC-grounded canonical description. The extracted text consists solely of boilerplate SEC cover page language from the 10-K filed 2026-02-27 (accession 000196473826000007) and does not include business description, segment data, revenue figures, product names, customer information, geographic breakdown, competitive positioning, or leadership details. No facts about Solventum's operations can be stated without risk of introducing unsupported claims.

Source: SEC 10-K, filed 2026-02-27

Industry: Surgical & Medical Instruments & Apparatus Peers: Align Technology Inc Cooper Companies Inc QuidelOrtho Corp DENTSPLY SIRONA Inc Haemonetics Corp Lantheus Holdings Inc Merit Medical Systems Inc Neogen Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support